{
    "clinical_study": {
        "@rank": "120855", 
        "arm_group": {
            "arm_group_label": "InterGard Synergy Vascular Graft", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "The purpose of the study is to assess the performance and safety of the InterGard Synergy\n      vascular graft."
        }, 
        "brief_title": "InterGard Synergy Post-Marketing Surveillance Study", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Aortic Aneurysm, Abdominal", 
            "Occlusive Disease of Artery of Lower Extremity"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Aneurysm", 
                "Aortic Aneurysm", 
                "Aortic Aneurysm, Abdominal"
            ]
        }, 
        "detailed_description": {
            "textblock": "Study of the device in patients with aneurysmal and occlusive disease of the abdominal aorta\n      and peripheral arteries."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients requiring an InterGard Synergy Vascular Graft\n\n        Exclusion Criteria:\n\n          -  Patients with contra-indications per InterGard Synergy Vascular Graft\n\n          -  Patients with current graft infection\n\n          -  Patients with a known allergy to collagen, triclosan or silver acetate\n\n          -  Patients who require urgent or emergent surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 1, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01698671", 
            "org_study_id": "MCV00010173"
        }, 
        "intervention": {
            "arm_group_label": "InterGard Synergy Vascular Graft", 
            "intervention_name": "InterGard Synergy Vascular Graft", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 24, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Graz, Vienna", 
                        "country": "Austria"
                    }, 
                    "name": "Study Centers"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankfurt, Karlsruhe", 
                        "country": "Germany"
                    }, 
                    "name": "Study Centers"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Heidelberg, Hamburg, Hanau", 
                        "country": "Germany"
                    }, 
                    "name": "Study Centers"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Austria", 
                "Germany"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "InterGard Synergy Post-Marketing Surveillance Study", 
        "overall_official": {
            "affiliation": "Krankenhaus Nordwest", 
            "last_name": "Max Zegelman, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Patency will be assessed by color-coded duplex ultrasound up to 6 months post implantation.\nComplications including the occurrence of graft infections will be assessed up to post implantation.", 
            "measure": "Graft Patency and Complications", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01698671"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Mortality rate will be assessed up to 6 months post implantation.", 
            "measure": "Mortality rate", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "Maquet Cardiovascular", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Maquet Cardiovascular", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}